ANTIBIOTIC DROPS DIN 02457512
Health Canada record
| Active ingredient(s) | GRAMICIDIN 0.025 MG; POLYMYXIN B SULFATE 10000 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Otic; Ophthalmic |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | S03AA30 ANTIINFECTIVES, COMBINATIONS |
| Original market date | 01-Jun-2017 |
| Current status date | 27-May-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GRAMICIDIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02208288 | ANTIBIOTIC CREAM | TECHNILAB PHARMA INC. | Cream | GRAMICIDIN 0.25 MG; POLYMYXIN B SULFATE 10000 UNIT | Cancelled Post Market |
| 00694371 | NEOSPORIN EYE-EAR SOLUTION | GLAXOSMITHKLINE INC | Solution | GRAMICIDIN 0.025 MG; POLYMYXIN B (POLYMYXIN B SULFATE) 10000 UNIT; NEOMYCIN (NEOMYCIN SULFATE) 1.75 MG | Cancelled Post Market |
International API supply for GRAMICIDIN
1 valid EDQM Certificates of Suitability from 1 holders. 1 active FDA Drug Master Files.
Request a quote for ANTIBIOTIC DROPS